{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T14:01:46Z","timestamp":1777816906170,"version":"3.51.4"},"reference-count":77,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_sjpain-2026-0007_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      The neurotrophin receptor TrkA is a clinically and genetically validated target in pain signaling. Anti-nerve growth factor (NGF) monoclonal antibodies have shown clinical efficacy but with side effects such as rapidly progressing osteoarthritis limiting their use, potentially mediated via inhibition of NGF\/p75NTR signaling. Therefore, we sought to identify novel and selective small molecule negative allosteric modulators of tropomyosin receptor kinase A (TrkA) and to verify their analgesic effect\n                      <jats:italic>in\u00a0vivo<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_sjpain-2026-0007_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We have identified ACD137 as a potent and selective negative allosteric modulator (NAM) of TrkA during a lead optimization program. The potency of ACD137 on TrkA and selectivity over TrkB was determined in cell-based assays. ACD137 was tested for its analgesic and anti-inflammatory effects in a model of chemotherapy induced peripheral neuropathy (CIPN) using paclitaxel and in the mono-iodo acetate (MIA)-induced osteoarthritis model in\u00a0rats.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_sjpain-2026-0007_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      ACD137 demonstrated an IC\n                      <jats:sub>50<\/jats:sub>\n                      -value on TrkA of 1.2\u202fnM and showed approximately 17,300- and 17,600-fold selectivivity for TrkA over TrkB and TrkC, respectively. After oral administration in rats, ACD137 reduced mechanical allodynia in the CIPN model in a dose-dependent manner with maximal analgesic efficacy similar to the effect of gabapentin. In a comparative arthritis study using the anti-NGF antibody tanezumab as comparator, ACD137 reduced both evoked and non-evoked pain behavior as well as inflammation with similar efficacy as tanezumab. Surprisingly, ACD137 demonstrated a significant protective effect against knee joint deterioration, something that was not observed with tanezumab.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_sjpain-2026-0007_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The data demonstrates that ACD137 is a potent, selective and\n                      <jats:italic>in\u00a0vivo<\/jats:italic>\n                      active negative allosteric modulator of TrkA exhibiting analgesic effects in models of neuropathic and nociceptive pain. The molecule possesses promising properties for further pre-clinical development.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/sjpain-2026-0007","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:08:12Z","timestamp":1777496892000},"source":"Crossref","is-referenced-by-count":0,"title":["Analgesic, anti-inflammatory and joint protective effects of ACD137, a selective negative allosteric modulator of TrkA, in models of chemotherapy-induced peripheral neuropathy and osteoarthritis"],"prefix":"10.1515","volume":"26","author":[{"given":"Pontus","family":"Forsell","sequence":"first","affiliation":[{"name":"AlzeCure Pharma AB , Huddinge , Sweden"},{"name":"Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics , Karolinska Institutet , Huddinge , Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Backlund","sequence":"additional","affiliation":[{"name":"AlzeCure Pharma AB , Huddinge , Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Lidell","sequence":"additional","affiliation":[{"name":"AlzeCure Pharma AB , Huddinge , Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azita","family":"Rasti","sequence":"additional","affiliation":[{"name":"AlzeCure Pharma AB , Huddinge , Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina Parrado","family":"Fernandez","sequence":"additional","affiliation":[{"name":"AlzeCure Pharma AB , Huddinge , Sweden"},{"name":"Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics , Karolinska Institutet , Huddinge , Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e4rta","family":"Segerdahl","sequence":"additional","affiliation":[{"name":"AlzeCure Pharma AB , Huddinge , Sweden"},{"name":"Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics , Karolinska Institutet , Huddinge , Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Sandin","sequence":"additional","affiliation":[{"name":"AlzeCure Pharma AB , Huddinge , Sweden"},{"name":"Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics , Karolinska Institutet , Huddinge , Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnar","family":"Nordvall","sequence":"additional","affiliation":[{"name":"AlzeCure Pharma AB , Huddinge , Sweden"},{"name":"Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics , Karolinska Institutet , Huddinge , Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"2026042921153609816_j_sjpain-2026-0007_ref_001","doi-asserted-by":"crossref","unstructured":"Levi-Montalcini, R. Effects of mouse tumor transplantation on the nervous system. Ann N Y Acad Sci 1952;55:330\u201344. https:\/\/doi.org\/10.1111\/j.1749-6632.1952.tb26548.x.","DOI":"10.1111\/j.1749-6632.1952.tb26548.x"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_002","doi-asserted-by":"crossref","unstructured":"Barde, YA, Edgar, D, Thoenen, H. Purification of a new neurotrophic factor from mammalian brain. EMBO J 1982;1:549\u201353. https:\/\/doi.org\/10.1002\/j.1460-2075.1982.tb01207.x.","DOI":"10.1002\/j.1460-2075.1982.tb01207.x"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_003","doi-asserted-by":"crossref","unstructured":"Ernfors, P, Ib\u00e1\u00f1ez, CF, Ebendal, T, Olson, L, Persson, H. Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain. Proc Natl Acad Sci U S A 1990;87:5454\u20138. https:\/\/doi.org\/10.1073\/pnas.87.14.5454.","DOI":"10.1073\/pnas.87.14.5454"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_004","doi-asserted-by":"crossref","unstructured":"Hallb\u00f6\u00f6k, F, Ib\u00e1\u00f1ez, CF, Persson, H. Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary. Neuron 1991;6:845\u201358. https:\/\/doi.org\/10.1016\/0896-6273(91)90180-8.","DOI":"10.1016\/0896-6273(91)90180-8"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_005","doi-asserted-by":"crossref","unstructured":"Reichardt, LF. Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 2006;361:1545\u201364. https:\/\/doi.org\/10.1098\/rstb.2006.1894.","DOI":"10.1098\/rstb.2006.1894"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_006","doi-asserted-by":"crossref","unstructured":"Underwood, CK, Coulson, EJ. The p75 neurotrophin receptor. Int J Biochem Cell Biol 2008;40:1664\u20138. https:\/\/doi.org\/10.1016\/j.biocel.2007.06.010.","DOI":"10.1016\/j.biocel.2007.06.010"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_007","doi-asserted-by":"crossref","unstructured":"Franco, ML, Nadezhdin, KD, Goncharuk, SA, Mineev, KS, Arseniev, AS, Vilar, M. Structural basis of the transmembrane domain dimerization and rotation in the activation mechanism of the TRKA receptor by nerve growth factor. J\u00a0Biol Chem 2020;295:275\u201386. https:\/\/doi.org\/10.1074\/jbc.ra119.011312.","DOI":"10.1074\/jbc.RA119.011312"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_008","doi-asserted-by":"crossref","unstructured":"Rabin, SJ, Cleghon, V, Kaplan, DR. SNT, a differentiation-specific target of neurotrophic factor-induced tyrosine kinase activity in neurons and PC12 cells. Mol Cell Biol 1993;13:2203\u201313. https:\/\/doi.org\/10.1128\/mcb.13.4.2203-2213.1993.","DOI":"10.1128\/MCB.13.4.2203"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_009","doi-asserted-by":"crossref","unstructured":"Meakin, SO, MacDonald, JIS, Gryz, EA, Kubu, CJ, Verdi, JM. The signaling adapter FRS-2 competes with shc for binding to the nerve growth factor receptor TrkA. J\u00a0Biol Chem 1999;274:9861\u201370. https:\/\/doi.org\/10.1074\/jbc.274.14.9861.","DOI":"10.1074\/jbc.274.14.9861"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_010","doi-asserted-by":"crossref","unstructured":"Kaplan, DR, Miller, FD. Signal transduction by the neutrophin receptors. Curr Opin Cell Biol 1997;9:213\u201321. https:\/\/doi.org\/10.1016\/s0955-0674(97)80065-8.","DOI":"10.1016\/S0955-0674(97)80065-8"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_011","doi-asserted-by":"crossref","unstructured":"Obermeier, A, Lammers, R, Wiesm\u00fcller, KH, Jung, G, Schlessinger, J, Ullrich, A. Identification of Trk binding sites for SHC and phosphatidylinositol 3\u2019-kinase and formation of a multimeric signaling complex. J\u00a0Biol Chem 1993;268:22963\u20136. https:\/\/doi.org\/10.1016\/s0021-9258(19)49410-6.","DOI":"10.1016\/S0021-9258(19)49410-6"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_012","doi-asserted-by":"crossref","unstructured":"Liu, H-Y, Meakin, SO. ShcB and ShcC activation by the Trk family of receptor tyrosine kinases*. J\u00a0Biol Chem 2002;277:26046\u201356. https:\/\/doi.org\/10.1074\/jbc.m111659200.","DOI":"10.1074\/jbc.M111659200"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_013","doi-asserted-by":"crossref","unstructured":"Sofroniew, MV, Howe, CL, Mobley, WC. Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 2001;24:1217\u201381. https:\/\/doi.org\/10.1146\/annurev.neuro.24.1.1217.","DOI":"10.1146\/annurev.neuro.24.1.1217"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_014","doi-asserted-by":"crossref","unstructured":"Obermeier, A, Halfter, H, Wiesm\u00fcller, KH, Jung, G, Schlessinger, J, Ullrich, A. Tyrosine 785 is a major determinant of Trk\u2010\u2010substrate interaction. EMBO J 1993;12:933\u201341. https:\/\/doi.org\/10.1002\/j.1460-2075.1993.tb05734.x.","DOI":"10.1002\/j.1460-2075.1993.tb05734.x"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_015","doi-asserted-by":"crossref","unstructured":"Robinson, KN, Manto, K, Buchsbaum, RJ, MacDonald, JIS, Meakin, SO. Neurotrophin-dependent tyrosine phosphorylation of Ras guanine-releasing factor 1 and associated neurite outgrowth is dependent on the HIKE domain of TrkA*. J\u00a0Biol Chem 2005;280:225\u201335. https:\/\/doi.org\/10.1074\/jbc.m410454200.","DOI":"10.1074\/jbc.M410454200"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_016","doi-asserted-by":"crossref","unstructured":"Regua, AT, Aguayo, NR, Jalboush, SA, Doheny, DL, Manore, SG, Zhu, D, et al.. TrkA interacts with and phosphorylates STAT3 to enhance gene transcription and promote breast cancer stem cells in triple-negative and HER2-Enriched breast cancers. Cancers 2021;13:2340. https:\/\/doi.org\/10.3390\/cancers13102340.","DOI":"10.3390\/cancers13102340"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_017","doi-asserted-by":"crossref","unstructured":"Pezet, S, McMahon, SB. Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci 2006;29:507\u201338. https:\/\/doi.org\/10.1146\/annurev.neuro.29.051605.112929.","DOI":"10.1146\/annurev.neuro.29.051605.112929"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_018","doi-asserted-by":"crossref","unstructured":"Barker, PA, Mantyh, P, Arendt-Nielsen, L, Viktrup, L, Tive, L. Nerve growth factor signaling and its contribution to pain. J\u00a0Pain Res 2020;13:1223\u201341. https:\/\/doi.org\/10.2147\/jpr.s247472.","DOI":"10.2147\/JPR.S247472"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_019","doi-asserted-by":"crossref","unstructured":"Zhang, X, Huang, J, McNaughton, PA. NGF rapidly increases membrane expression of TRPV1\u00a0heat-gated ion channels. EMBO J 2005;24:4211\u201323. https:\/\/doi.org\/10.1038\/sj.emboj.7600893.","DOI":"10.1038\/sj.emboj.7600893"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_020","doi-asserted-by":"crossref","unstructured":"Bonnington, JK, McNaughton, PA. Signalling pathways involved in the sensitisation of mouse nociceptive neurones by nerve growth factor. J\u00a0Physiol 2003;551:433\u201346. https:\/\/doi.org\/10.1113\/jphysiol.2003.039990.","DOI":"10.1113\/jphysiol.2003.039990"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_021","doi-asserted-by":"crossref","unstructured":"Brackenbury, WJ, Djamgoz, MBA. Nerve growth factor enhances voltage-gated Na+ channel activity and transwell migration in Mat-LyLu rat prostate cancer cell line. J\u00a0Cell Physiol 2007;210:602\u20138. https:\/\/doi.org\/10.1002\/jcp.20846.","DOI":"10.1002\/jcp.20846"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_022","doi-asserted-by":"crossref","unstructured":"Toledo-Aral, JJ, Moss, BL, He, ZJ, Koszowski, AG, Whisenand, T, Levinson, SR, et al.. Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons. Proc Natl Acad Sci U S A 1997;94:1527\u201332. https:\/\/doi.org\/10.1073\/pnas.94.4.1527.","DOI":"10.1073\/pnas.94.4.1527"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_023","doi-asserted-by":"crossref","unstructured":"Diss, JKJ, Calissano, M, Gascoyne, D, Djamgoz, MBA, Latchman, DS. Identification and characterization of the promoter region of the Nav1.7\u00a0voltage-gated sodium channel gene (SCN9A). Mol Cell Neurosci 2008;37:537\u201347. https:\/\/doi.org\/10.1016\/j.mcn.2007.12.002.","DOI":"10.1016\/j.mcn.2007.12.002"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_024","doi-asserted-by":"crossref","unstructured":"Hameed, S. Nav1.7 and Nav1.8: role in the pathophysiology of pain. Mol Pain 2019;15:1744806919858801. https:\/\/doi.org\/10.1177\/1744806919858801.","DOI":"10.1177\/1744806919858801"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_025","doi-asserted-by":"crossref","unstructured":"Kayama, Y, Shibata, M, Takizawa, T, Ibata, K, Nakahara, J, Shimizu, T, et al.. Signaling pathways relevant to nerve growth factor-induced upregulation of transient receptor potential M8 expression. Neuroscience 2017;367:178\u201388. https:\/\/doi.org\/10.1016\/j.neuroscience.2017.10.037.","DOI":"10.1016\/j.neuroscience.2017.10.037"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_026","doi-asserted-by":"crossref","unstructured":"Takano, S, Uchida, K, Itakura, M, Iwase, D, Aikawa, J, Inoue, G, et al.. Transforming growth factor-\u03b2 stimulates nerve growth factor production in osteoarthritic synovium. BMC Muscoskelet Disord 2019;20:204. https:\/\/doi.org\/10.1186\/s12891-019-2595-z.","DOI":"10.1186\/s12891-019-2595-z"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_027","doi-asserted-by":"crossref","unstructured":"Uchida, K, Takano, S, Matsumoto, T, Nagura, N, Inoue, G, Itakura, M, et al.. Transforming growth factor activating kinase 1 regulates extracellular matrix degrading enzymes and pain-related molecule expression following tumor necrosis factor-\u03b1 stimulation of synovial cells: an in\u00a0vitro study. BMC Muscoskelet Disord 2017;18:283. https:\/\/doi.org\/10.1186\/s12891-017-1648-4.","DOI":"10.1186\/s12891-017-1648-4"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_028","doi-asserted-by":"crossref","unstructured":"Dai, W-L, Yan, B, Bao, Y-N, Fan, J-F, Liu, J-H. Suppression of peripheral NGF attenuates neuropathic pain induced by chronic constriction injury through the TAK1-MAPK\/NF-\u03baB signaling pathways. Cell Commun Signal 2020;18:66. https:\/\/doi.org\/10.1186\/s12964-020-00556-3.","DOI":"10.1186\/s12964-020-00556-3"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_029","doi-asserted-by":"crossref","unstructured":"M\u00f6ller, K\u00c4, Berge, OG, Finn, A, Stenfors, C, Svensson, CI. Using gait analysis to assess weight bearing in rats with Freund\u05f3s complete adjuvant-induced monoarthritis to improve predictivity: interfering with the cyclooxygenase and nerve growth factor pathways. Eur J Pharmacol 2015;756:75\u201384. https:\/\/doi.org\/10.1016\/j.ejphar.2015.02.050.","DOI":"10.1016\/j.ejphar.2015.02.050"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_030","doi-asserted-by":"crossref","unstructured":"Xu, L, Nwosu, LN, Burston, JJ, Millns, PJ, Sagar, DR, Mapp, PI, et al.. The anti-NGF antibody muMab 911 both prevents and reverses pain behaviour and subchondral osteoclast numbers in a rat model of osteoarthritis pain. Osteoarthr Cartil 2016;24:1587\u201395. https:\/\/doi.org\/10.1016\/j.joca.2016.05.015.","DOI":"10.1016\/j.joca.2016.05.015"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_031","doi-asserted-by":"crossref","unstructured":"Dietz, BW, Nakamura, MC, Bell, MT, Lane, NE. Targeting nerve growth factor for pain management in osteoarthritis-clinical efficacy and safety. Rheum Dis Clin N Am 2021;47:181\u201395. https:\/\/doi.org\/10.1016\/j.rdc.2020.12.003.","DOI":"10.1016\/j.rdc.2020.12.003"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_032","doi-asserted-by":"crossref","unstructured":"Hochberg, MC. Serious joint-related adverse events in randomized controlled trials of anti-nerve growth factor monoclonal antibodies. Osteoarthr Cartil 2015;23:S18\u201321. https:\/\/doi.org\/10.1016\/j.joca.2014.10.005.","DOI":"10.1016\/j.joca.2014.10.005"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_033","doi-asserted-by":"crossref","unstructured":"Neogi, T, Hunter, DJ, Churchill, M, Shirinsky, I, White, A, Guermazi, A, et al.. Observed efficacy and clinically important improvements in participants with osteoarthritis treated with subcutaneous tanezumab: results from a 56-week randomized NSAID-controlled study. Arthritis Res Ther 2022;24:78. https:\/\/doi.org\/10.1186\/s13075-022-02759-0.","DOI":"10.1186\/s13075-022-02759-0"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_034","doi-asserted-by":"crossref","unstructured":"Wang, Y, Yang, K, Li, G, Liu, R, Liu, J, Li, J, et al.. p75NTR\u00a0\u2212\/\u2212 mice exhibit an alveolar bone loss phenotype and inhibited PI3K\/Akt\/\u03b2-catenin pathway. Cell Prolif 2020;53:e12800. https:\/\/doi.org\/10.1111\/cpr.12800.","DOI":"10.1111\/cpr.12800"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_035","doi-asserted-by":"crossref","unstructured":"Zhao, M, Wang, Y, Li, G, Li, J, Yang, K, Liu, C, et al.. The role and potential mechanism of p75NTR in mineralization via in\u00a0vivo p75NTR knockout mice and in\u00a0vitro ectomesenchymal stem cells. Cell Prolif 2020;53:e12758. https:\/\/doi.org\/10.1111\/cpr.12758.","DOI":"10.1111\/cpr.12758"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_036","doi-asserted-by":"crossref","unstructured":"Li, J, Zhao, M, Wang, Y, Shen, M, Wang, S, Tang, M, et al.. p75NTR optimizes the osteogenic potential of human periodontal ligament stem cells by up-regulating \u03b11 integrin expression. J\u00a0Cell Mol Med 2020;24:7563\u201375. https:\/\/doi.org\/10.1111\/jcmm.15390.","DOI":"10.1111\/jcmm.15390"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_037","doi-asserted-by":"crossref","unstructured":"Wu, Z, Li, N, Luo, Z, Chen, Z, He, X, Shi, F, et al.. The p75 neurotrophin receptor controls the skeletal stem cell niche through sensory innervation. Dev Cell 2025;61:259\u201375. https:\/\/doi.org\/10.1016\/j.devcel.2025.09.012.","DOI":"10.1016\/j.devcel.2025.09.012"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_038","doi-asserted-by":"crossref","unstructured":"Zhao, L, Lai, Y, Jiao, H, Huang, J. Nerve growth factor receptor limits inflammation to promote remodeling and repair of osteoarthritic joints. Nat Commun 2024;15:3225. https:\/\/doi.org\/10.1038\/s41467-024-47633-6.","DOI":"10.1038\/s41467-024-47633-6"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_039","doi-asserted-by":"crossref","unstructured":"Thress, K, Macintyre, T, Wang, H, Whitston, D, Liu, ZY, Hoffmann, E, et al.. Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway. Mol Cancer Therapeut 2009;8:1818\u201327. https:\/\/doi.org\/10.1158\/1535-7163.mct-09-0036.","DOI":"10.1158\/1535-7163.MCT-09-0036"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_040","doi-asserted-by":"crossref","unstructured":"Skerratt, S, Andrews, MD, Bagal, SK, Bilsland, J, Brown, D, Bungay, PJ, et al.. The discovery of a potent, selective and peripherally restricted pan-trk inhibitor (PF-06273340) for the treatment of pain. J\u00a0Med Chem 2016;59:10084\u201399. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b00850.","DOI":"10.1021\/acs.jmedchem.6b00850"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_041","doi-asserted-by":"crossref","unstructured":"Bailey, JJ, Jaworski, C, Tung, D, W\u00e4ngler, C, W\u00e4ngler, B, Schirrmacher, R. Tropomyosin receptor kinase inhibitors: an updated patent review for 2016\u20132019. Expert Opin Ther Pat 2020;30:325\u201339. https:\/\/doi.org\/10.1080\/13543776.2020.1737011.","DOI":"10.1080\/13543776.2020.1737011"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_042","doi-asserted-by":"crossref","unstructured":"Bagal, SK, Andrews, M, Bechle, BM, Bian, J, Bilsland, J, Blakemore, DC, et al.. Discovery of potent, selective, and peripherally restricted pan-trk kinase inhibitors for the treatment of pain. J\u00a0Med Chem 2018;61:6779\u2013800. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b00633.","DOI":"10.1021\/acs.jmedchem.8b00633"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_043","doi-asserted-by":"crossref","unstructured":"Nwosu, LN, Mapp, PI, Chapman, V, Walsh, DA. Blocking the tropomyosin receptor kinase A (TrkA) receptor inhibits pain behaviour in two rat models of osteoarthritis. Ann Rheum Dis 2016;75:1246\u201354. https:\/\/doi.org\/10.1136\/annrheumdis-2014-207203.","DOI":"10.1136\/annrheumdis-2014-207203"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_044","doi-asserted-by":"crossref","unstructured":"Ashraf, S, Bouhana, KS, Pheneger, J, Andrews, SW, Walsh, DA. Selective inhibition of tropomyosin-receptor-kinase A (TrkA) reduces pain and joint damage in two rat models of inflammatory arthritis. Arthritis Res Ther 2016;18:97. https:\/\/doi.org\/10.1186\/s13075-016-0996-z.","DOI":"10.1186\/s13075-016-0996-z"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_045","doi-asserted-by":"crossref","unstructured":"Hsiang, HW, Girard, BM, Ratkovits, L, Campbell, SE, Vizzard, MA. Effects of pharmacological neurotrophin receptor inhibition on bladder function in female mice with cyclophosphamide-induced cystitis. Front Urol 2022;2. https:\/\/doi.org\/10.3389\/fruro.2022.1037511.","DOI":"10.3389\/fruro.2022.1037511"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_046","doi-asserted-by":"crossref","unstructured":"Bagal, SK, Omoto, K, Blakemore, DC, Bungay, PJ, Bilsland, JG, Clarke, PJ, et al.. Discovery of allosteric, potent, subtype selective, and peripherally restricted TrkA kinase inhibitors. J\u00a0Med Chem 2019;62:247\u201365. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b00280.","DOI":"10.1021\/acs.jmedchem.8b00280"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_047","doi-asserted-by":"crossref","unstructured":"Su, H-P, Rickert, K, Burlein, C, Narayan, K, Bukhtiyarova, M, Hurzy, DM, et al.. Structural characterization of nonactive site, TrkA-selective kinase inhibitors. Proc Natl Acad Sci 2017;114. https:\/\/doi.org\/10.1073\/pnas.1611577114.","DOI":"10.1073\/pnas.1611577114"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_048","doi-asserted-by":"crossref","unstructured":"Subramanian, G, Bowen, SJ, Zhu, Y, Roush, N, Zachary, T, Javens, C, et al.. Type 2 inhibitor leads of human tropomyosin receptor kinase (hTrkA). Bioorg Med Chem Lett 2019;29:126624. https:\/\/doi.org\/10.1016\/j.bmcl.2019.126624.","DOI":"10.1016\/j.bmcl.2019.126624"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_049","doi-asserted-by":"crossref","unstructured":"Subramanian, G, Vairagoundar, R, Bowen, SJ, Roush, N, Zachary, T, Javens, C, et al.. Synthetic inhibitor leads of human tropomyosin receptor kinase A ( h TrkA). RSC Med Chem 2020;11:370\u20137. https:\/\/doi.org\/10.1039\/c9md00554d.","DOI":"10.1039\/C9MD00554D"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_050","doi-asserted-by":"crossref","unstructured":"Subramanian, G, Duclos, B, Johnson, PD, Williams, T, Ross, JT, Bowen, SJ, et al.. In pursuit of an allosteric human tropomyosin kinase A (hTrkA) inhibitor for chronic pain. ACS Med Chem Lett 2021;12:1847\u201352. https:\/\/doi.org\/10.1021\/acsmedchemlett.1c00483.","DOI":"10.1021\/acsmedchemlett.1c00483"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_051","doi-asserted-by":"crossref","unstructured":"Subramanian, G, Johnson, PD, Zachary, T, Roush, N, Zhu, Y, Bowen, SJ, et al.. Deciphering the allosteric binding mechanism of the human tropomyosin receptor kinase A (hTrkA) inhibitors. ACS Chem Biol 2019;14:1205\u201316. https:\/\/doi.org\/10.1021\/acschembio.9b00126.","DOI":"10.1021\/acschembio.9b00126"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_052","doi-asserted-by":"crossref","unstructured":"Furuya, N, Momose, T, Katsuno, K, Fushimi, N, Muranaka, H, Handa, C, et al.. The juxtamembrane region of TrkA kinase is critical for inhibitor selectivity. Bioorg Med Chem Lett 2017;27:1233\u20136. https:\/\/doi.org\/10.1016\/j.bmcl.2017.01.056.","DOI":"10.1016\/j.bmcl.2017.01.056"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_053","unstructured":"Lidell, V, Rasti, A, Nordvall, G, Backlund, M, Juric, S, Parrado-Fernandez, C, et al.. Analgesic and anti-inflammatory effects of small molecule negative allosteric modulators of TrkA. Poster PTH226, IASP World Congress on Pain; 2022."},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_054","unstructured":"Forsell, P, Segerdahl, M. Pharmacological effects of ACD137, a small molecule negative allosteric modulator of TrkA. Poster, PNT-0409-045, 9th International Congress on Neuropathic Pain; 2025."},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_055","doi-asserted-by":"crossref","unstructured":"Fernandez, CP, Juric, S, Backlund, M, Dahlstr\u00f6m, M, Madjid, N, Lidell, V, et al.. Neuroprotective and disease-modifying effects of the triazinetrione ACD856, a positive allosteric modulator of trk-receptors for the treatment of cognitive dysfunction in alzheimer\u2019s disease. Int J Mol Sci 2023;24:11159. https:\/\/doi.org\/10.3390\/ijms241311159.","DOI":"10.3390\/ijms241311159"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_056","doi-asserted-by":"crossref","unstructured":"Hardowar, L, Valentine, T, Lobo, MDV, Corbett, J, Owen, B, Skeen, O, et al.. Cisplatin induced alterations in nociceptor developmental trajectory elicits a TrkA dependent platinum-based chemotherapy induced neuropathic pain. Neuroscience 2024;559:39\u201353. https:\/\/doi.org\/10.1016\/j.neuroscience.2024.08.028.","DOI":"10.1016\/j.neuroscience.2024.08.028"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_057","doi-asserted-by":"crossref","unstructured":"Lobo, MDV, Hardowar, L, Valentine, T, Tomblin, L, Guest, C, Sharma, D, et al.. Early life cisplatin exposure induces nerve growth factor mediated neuroinflammation and chemotherapy induced neuropathic pain. Dis Model Mech 2024;17:dmm.052062. https:\/\/doi.org\/10.1242\/dmm.052062.","DOI":"10.1242\/dmm.052062"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_058","doi-asserted-by":"crossref","unstructured":"Kim, Y, Je, M-A, Jeong, M, Kwon, H, Jang, A, Kim, J, et al.. Upregulation of NGF\/TrkA-Related proteins in dorsal root ganglion of paclitaxel-induced peripheral neuropathy animal model. J\u00a0Pain Res 2024;17:3919\u201332. https:\/\/doi.org\/10.2147\/jpr.s470671.","DOI":"10.2147\/JPR.S470671"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_059","doi-asserted-by":"crossref","unstructured":"Liang, Z, Tan, J, Tang, L, Xie, Z, Chen, G, Liu, G, et al.. NGF monoclonal antibody DS002 alleviates chemotherapy-induced peripheral neuropathy in rats. Acta Pharmacol Sin 2022;43:2841\u20137. https:\/\/doi.org\/10.1038\/s41401-022-00904-8.","DOI":"10.1038\/s41401-022-00904-8"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_060","doi-asserted-by":"crossref","unstructured":"de Valente, JS. The pharmacology of pain associated with the monoiodoacetate model of osteoarthritis. Front Pharmacol 2019;10:974. https:\/\/doi.org\/10.3389\/fphar.2019.00974.","DOI":"10.3389\/fphar.2019.00974"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_061","doi-asserted-by":"crossref","unstructured":"Ishikawa, G, Koya, Y, Tanaka, H, Nagakura, Y. Long-term analgesic effect of a single dose of anti-NGF antibody on pain during motion without notable suppression of joint edema and lesion in a rat model of osteoarthritis. Osteoarthr Cartil 2015;23:925\u201332. https:\/\/doi.org\/10.1016\/j.joca.2015.02.002.","DOI":"10.1016\/j.joca.2015.02.002"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_062","doi-asserted-by":"crossref","unstructured":"Ding, Y, Liu, X, Chen, C, Yin, C, Sun, X. Global, regional, and national trends in osteoarthritis disability-adjusted life years (DALYs) from 1990 to 2019: a comprehensive analysis of the global burden of disease study. Public Health 2024;226:261\u201372. https:\/\/doi.org\/10.1016\/j.puhe.2023.10.030.","DOI":"10.1016\/j.puhe.2023.10.030"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_063","doi-asserted-by":"crossref","unstructured":"D\u2019Arcy, Y, Mantyh, P, Yaksh, T, Donevan, S, Hall, J, Sadrarhami, M, et al.. Treating osteoarthritis pain: mechanisms of action of acetaminophen, nonsteroidal anti-inflammatory drugs, opioids, and nerve growth factor antibodies. Postgrad Med J 2021;133:879\u201394. https:\/\/doi.org\/10.1080\/00325481.2021.1949199.","DOI":"10.1080\/00325481.2021.1949199"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_064","doi-asserted-by":"crossref","unstructured":"Hochberg, MC, Tive, LA, Abramson, SB, Vignon, E, Verburg, KM, West, CR, et al.. When is osteonecrosis not osteonecrosis?: adjudication of reported serious adverse joint events in the tanezumab clinical development program. Arthritis Rheumatol 2016;68:382\u201391. https:\/\/doi.org\/10.1002\/art.39492.","DOI":"10.1002\/art.39492"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_065","doi-asserted-by":"crossref","unstructured":"Li, G, Liu, J, Wang, Y, Yang, K, Zhao, M, Xiao, Y, et al.. LNGFR targets the Wnt\/\u03b2-catenin pathway and promotes the osteogenic differentiation in rat ectomesenchymal stem cells. Sci Rep 2017;7:11021. https:\/\/doi.org\/10.1038\/s41598-017-11555-9.","DOI":"10.1038\/s41598-017-11555-9"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_066","doi-asserted-by":"crossref","unstructured":"Shan, P, Wang, X, Zhang, Y, Teng, Z, Zhang, Y, Jin, Q, et al.. P75 neurotrophin receptor positively regulates the odontogenic\/osteogenic differentiation of ectomesenchymal stem cells via nuclear factor kappa-B signaling pathway. Bioengineered 2022;13:11201\u201313. https:\/\/doi.org\/10.1080\/21655979.2022.2063495.","DOI":"10.1080\/21655979.2022.2063495"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_067","doi-asserted-by":"crossref","unstructured":"Li, G, Liu, J, Zhao, M, Wang, Y, Yang, K, Liu, C, et al.. SOST, an LNGFR target, inhibits the osteogenic differentiation of rat ectomesenchymal stem cells. Cell Prolif 2018;51:e12412. https:\/\/doi.org\/10.1111\/cpr.12412.","DOI":"10.1111\/cpr.12412"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_068","doi-asserted-by":"crossref","unstructured":"Farrell, M, Waibel, FWA, Carrera, I, Spattini, G, Clark, L, Adams, RJ, et al.. Musculoskeletal adverse events in dogs receiving bedinvetmab (Librela). Front Vet Sci 2025;12:1581490. https:\/\/doi.org\/10.3389\/fvets.2025.1581490.","DOI":"10.3389\/fvets.2025.1581490"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_069","doi-asserted-by":"crossref","unstructured":"Sarezky, J, Sachs, G, Elinzano, H, Stavros, K. Cancer and peripheral nerve disease. Clin Geriatr Med 2021;37:289\u2013300. https:\/\/doi.org\/10.1016\/j.cger.2021.01.003.","DOI":"10.1016\/j.cger.2021.01.003"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_070","doi-asserted-by":"crossref","unstructured":"Tay, N, Laakso, E-L, Schweitzer, D, Endersby, R, Vetter, I, Starobova, H. Chemotherapy-induced peripheral neuropathy in children and adolescent cancer patients. Front Mol Biosci 2022;9:1015746. https:\/\/doi.org\/10.3389\/fmolb.2022.1015746.","DOI":"10.3389\/fmolb.2022.1015746"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_071","doi-asserted-by":"crossref","unstructured":"Othumpangat, S, Gibson, LF, Samsell, L, Piedimonte, G. NGF is an essential survival factor for bronchial epithelial cells during respiratory syncytial virus infection. PLoS One 2009;4:e6444. https:\/\/doi.org\/10.1371\/journal.pone.0006444.","DOI":"10.1371\/journal.pone.0006444"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_072","doi-asserted-by":"crossref","unstructured":"Minnone, G, Benedetti, FD, Bracci-Laudiero, L. NGF and its receptors in the regulation of inflammatory response. Int J Mol Sci 2017;18. https:\/\/doi.org\/10.3390\/ijms18051028.","DOI":"10.3390\/ijms18051028"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_073","doi-asserted-by":"crossref","unstructured":"Tortorolo, L, Langer, A, Polidori, G, Vento, G, Stampachiacchere, B, Aloe, L, et al.. Neurotrophin overexpression in lower airways of infants with respiratory syncytial virus infection. Am J Respir Crit Care Med 2005;172:233\u20137. https:\/\/doi.org\/10.1164\/rccm.200412-1693oc.","DOI":"10.1164\/rccm.200412-1693OC"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_074","doi-asserted-by":"crossref","unstructured":"Chiaretti, A, Pulitan\u00f2, S, Conti, G, Barone, G, Buonsenso, D, Manni, L, et al.. Interleukin and neurotrophin up-regulation correlates with severity of H1N1 infection in children: a case-control study. Int J Infect Dis 2013;17:e1186\u201393. https:\/\/doi.org\/10.1016\/j.ijid.2013.07.006.","DOI":"10.1016\/j.ijid.2013.07.006"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_075","doi-asserted-by":"crossref","unstructured":"Sanchez, S, Flannery, BH, Murphy, H, Huang, Q, Ly, H, Liang, Y. Cellular receptor tyrosine kinase signaling plays important roles in SARS-CoV-2 infection. Pathogens 2025;14:333. https:\/\/doi.org\/10.3390\/pathogens14040333.","DOI":"10.3390\/pathogens14040333"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_076","doi-asserted-by":"crossref","unstructured":"Morin, CB, Misery, L. Emerging treatments and novel pathways in Pruritus. J\u00a0Cutan Med Surg 2019;23:528\u201336. https:\/\/doi.org\/10.1177\/1203475419852050.","DOI":"10.1177\/1203475419852050"},{"key":"2026042921153609816_j_sjpain-2026-0007_ref_077","doi-asserted-by":"crossref","unstructured":"Paller, AS, Kabashima, K, Bieber, T. Therapeutic pipeline for atopic dermatitis: end of the drought? J\u00a0Allergy Clin Immunol 2017;140:633\u201343. https:\/\/doi.org\/10.1016\/j.jaci.2017.07.006.","DOI":"10.1016\/j.jaci.2017.07.006"}],"container-title":["Scandinavian Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/sjpain-2026-0007\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/sjpain-2026-0007\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:20:22Z","timestamp":1777497622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/sjpain-2026-0007\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,4,27]]},"published-print":{"date-parts":[[2026,1,23]]}},"alternative-id":["10.1515\/sjpain-2026-0007"],"URL":"https:\/\/doi.org\/10.1515\/sjpain-2026-0007","relation":{},"ISSN":["1877-8879"],"issn-type":[{"value":"1877-8879","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"20260007"}}